1 completed, 1 terminated, 1 withdrawn. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow TAK-137: new trials by email Literature Review of TAK-137 trials Research Report on TAK-137
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1, Single and Multiple Dose Study of TAK-137 TAK-137 5 mg tablet, TAK-137 placebo tablet, TAK-137 5 mg tablet, TAK-137 placebo tablet or TAK-137 0.5 mg tablet, TAK-137 placebo tablet, TAK-137 5mg tablet, TAK-137 placebo tablet - Healthy Japanese Adult Male | Phase 1 | Withdrawn | Takeda | 2014-11-01 | 2015-11-26 | |
| Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder. TAK-137, TAK-137 Placebo - Attention-Deficit/Hyperactivity Disorder | Phase 1 | Terminated | Takeda | 47 | 2014-06-01 | 2016-07-11 |
| Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-137 in Healthy Participants TAK-137, Placebo - Dose Finding Study | Phase 1 | Completed | Takeda | 47 | 2013-06-01 | 2015-02-10 |
Attention Deficit Disorder with Hyperactivity (1)
Takeda (3)
Japan (1) · United States (1)